440 related articles for article (PubMed ID: 29217683)
1. Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice.
Steinmetz AB; Stern SA; Kohtz AS; Descalzi G; Alberini CM
J Neurosci; 2018 Jan; 38(4):1015-1029. PubMed ID: 29217683
[TBL] [Abstract][Full Text] [Related]
2. Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice.
Wu J; de Theije CGM; da Silva SL; Abbring S; van der Horst H; Broersen LM; Willemsen L; Kas M; Garssen J; Kraneveld AD
Brain Behav Immun; 2017 Jan; 59():273-287. PubMed ID: 27640900
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
[TBL] [Abstract][Full Text] [Related]
4. The adenosine A
Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
[TBL] [Abstract][Full Text] [Related]
5. Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T
Ansari MA; Attia SM; Nadeem A; Bakheet SA; Raish M; Khan TH; Al-Shabanah OA; Ahmad SF
Mol Cell Neurosci; 2017 Jul; 82():76-87. PubMed ID: 28465254
[TBL] [Abstract][Full Text] [Related]
6. Resolving neuroinflammatory and social deficits in ASD model mice: Dexmedetomidine downregulates NF-κB/IL-6 pathway via α2AR.
Liang ZK; Xiong W; Wang C; Chen L; Zou X; Mai JW; Dong B; Guo C; Xin WJ; Luo DX; Xu T; Feng X
Brain Behav Immun; 2024 Jul; 119():84-95. PubMed ID: 38552922
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 2 (IGF-2) rescues social deficits in NLG3
Pizzarelli R; Pimpinella D; Jacobs C; Tartacca A; Kullolli U; Monyer H; Alberini CM; Griguoli M
Front Cell Neurosci; 2023; 17():1332179. PubMed ID: 38298376
[TBL] [Abstract][Full Text] [Related]
8. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
[TBL] [Abstract][Full Text] [Related]
9. Taurine Improved Autism-Like Behaviours and Defective Neurogenesis of the Hippocampus in BTBR Mice through the PTEN/mTOR/AKT Signalling Pathway.
Xiaoyan H; Zhaoxi Y; Lingli Z; Jinyuan C; Wen Q
Folia Biol (Praha); 2024; 70(1):45-52. PubMed ID: 38830122
[TBL] [Abstract][Full Text] [Related]
10. Treatment of autistic spectrum disorder with insulin-like growth factors.
Riikonen R
Eur J Paediatr Neurol; 2016 Nov; 20(6):816-823. PubMed ID: 27562096
[TBL] [Abstract][Full Text] [Related]
11. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM
Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869
[TBL] [Abstract][Full Text] [Related]
13. Genetic modifications associated with ketogenic diet treatment in the BTBR
Mychasiuk R; Rho JM
Autism Res; 2017 Mar; 10(3):456-471. PubMed ID: 27529337
[TBL] [Abstract][Full Text] [Related]
14. The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alanazi AZ; Alsanea S; As Sobeai HM; Almutairi MM; Mahmood HM; Attia SM
Brain Res Bull; 2019 Oct; 152():27-34. PubMed ID: 31299319
[TBL] [Abstract][Full Text] [Related]
15. Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: A novel animal model of ASD.
Ebihara K; Fujiwara H; Awale S; Dibwe DF; Araki R; Yabe T; Matsumoto K
Behav Brain Res; 2017 Sep; 334():6-15. PubMed ID: 28743598
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice.
Xing X; Zhang J; Wu K; Cao B; Li X; Jiang F; Hu Z; Xia K; Li JD
Sci Rep; 2019 Feb; 9(1):3041. PubMed ID: 30816216
[TBL] [Abstract][Full Text] [Related]
17. mTOR plays an important role in cow's milk allergy-associated behavioral and immunological deficits.
Wu J; de Theije CG; da Silva SL; van der Horst H; Reinders MT; Broersen LM; Willemsen LE; Kas MJ; Garssen J; Kraneveld AD
Neuropharmacology; 2015 Oct; 97():220-32. PubMed ID: 26027949
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells.
Prem S; Dev B; Peng C; Mehta M; Alibutud R; Connacher RJ; St Thomas M; Zhou X; Matteson P; Xing J; Millonig JH; DiCicco-Bloom E
Elife; 2024 Mar; 13():. PubMed ID: 38525876
[TBL] [Abstract][Full Text] [Related]
19. Insulin-Like Growth Factor and Insulin-Like Growth Factor Receptor Expression in Human Idiopathic Autism Fusiform Gyrus Tissue.
Cioana M; Michalski B; Fahnestock M
Autism Res; 2020 Jun; 13(6):897-907. PubMed ID: 32154665
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.
Rhine MA; Parrott JM; Schultz MN; Kazdoba TM; Crawley JN
Autism Res; 2019 Mar; 12(3):401-421. PubMed ID: 30653853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
